The next step in Medical Affairs and MSL excellence - BCMAS® for Enterprise

Empower Your Medical Science Liaisons (MSLs) with the Only Globally Recognized Certification

Trusted by over 250+ pharma, biotech and healthcare organizations

  • cardinal
  • novartis
  • abbvie
  • gilead
  • gsk
  • novo+nordisk
  • pfizer
  • roche
  • sanofi
  • takeda
  • cardinal
  • novartis
  • abbvie
  • gilead
  • gsk
  • novo+nordisk
  • pfizer
  • roche
  • sanofi
  • takeda
?

DID YOU KNOW?

87% of KOLs prefer speaking with an MSL who has BCMAS® Board Certification1

The Board Certified Medical Affairs Specialist (BCMAS® for Enterprise) program equips your team with the skills, credibility, and expertise needed to excel in today's competitive pharmaceutical industry. Trusted by over 300 top pharmaceutical and biotech companies globally, BCMAS® is the gold standard for Medical Affairs professional teams.

92 percentage

BCMAS® graduates recommend the program for its comprehensive content

75 percentage

Medical Affairs Professionals say BCMAS helped them achieve their professional goals & objectives

msl+interacting+with+kol

BCMAS: The Competitive Edge for Your Organization

Mitigate Risk and Enhance Credibility

  • Improve Credibility: 87% of healthcare providers (HCPs) prefer speaking with BCMAS® board-certified MSLs.
  • Avoid Regulatory Vulnerabilities: Non-certified professionals may lack the compliance expertise required to navigate complex regulations.
  • Inefficient Communication: Misaligned messaging can harm relationships with HCPs and key opinion leaders (KOLs).

BCMAS® for Enterprise ensures your MSLs meet the highest ethical and regulatory standards, fostering trust and confidence with stakeholders.

Boost Team Performance and Strategic Impact

  • 80% Knowledge Improvement: Graduates report significant increases in proficiency across compliance, clinical trial design, pharmacovigilance, and more.
  • Proven ROI: Certified teams demonstrate stronger stakeholder engagement and deliver measurable business results.
  • Continuous Learning - Proprietary AI-enhanced micro-learnings future-proof teams to deal with complex challenges.

Equip your team with tools & practical frameworks, such as KPI guides, AI-driven micro-learnings, & strategy development plans

Drive Organizational Success

Seamless Collaboration: Align Medical Affairs, Clinical, and Commercial teams with ethical, data-driven strategies.

  • Practical Ready Use Tools: Empower MSLs and team leaders to build medical affairs strategies, and execute and manage KOL networks.
  • Master Real World Evidence and become experts at scientific storytelling.
  • Unified Knowledge: Establish a consistent and reliable knowledge foundation in medical affairs to ensure your team operates with accuracy and cohesion.

BCMAS® fosters a culture of excellence, enabling your organization to lead in medical innovation and compliance.

What Makes BCMAS® for Enterprise Essential for Teams

Designed by Industry Experts, for Industry Leaders

Every module is authored and curated by top professionals from leading pharmaceutical and biotech organizations. The program is tailored specifically for the challenges and opportunities faced by Medical Science Liaison teams in corporate environments.

79 percentage

rated the program 4.8 out of 5, citing its ability to meet or exceed their professional needs.

Strategic Mastery of Medical Affairs: Core Functions, Tools & Processes.

Advanced Concepts in Medical Affairs: Medical Devices & Diagnostics

Medical Science Liaison Excellence

MSL & Medical Affairs Business Acumen

Fundamentals of Medical Affairs Compliance Concepts

Drug Safety & REMS

Health Economics Outcomes Research: Strategic Insights and Modeling for Medical Affairs Professionals

Clinical Trial Design & Drug Development

Regulatory Affairs

Scientific Storytelling: Advanced Concepts in Evidence Generation & Clinical Trial Appraisal

Master Medical & Scientific Communications

Core Concepts in Medical Information

Enhanced Manager Tools Keep You Informed

Dashboards: Track team performance and identify growth opportunities.

AI Micro-Learnings: Fill training gaps in real-time with personalized content.

Slide 1

The Risks of Inaction

1

Loss of trust and credibility with HCPs and KOLs.

2

Missed opportunities to engage key stakeholders effectively.

3

Increased vulnerability to regulatory scrutiny and compliance failures.

BCMAS Program Information

The Path to Excellence Starts Here

Contact us to learn how BCMAS® for Enterprise can transform your Medical Affairs team and deliver measurable business results.

The BCMAS® for Enterprise is accredited by the International Accreditors for Continuing Education & Training/American National Standards Institute (IACET/ANSI)

Contact us to learn more